HPLC method development for fampridine using Analytical Quality by Design approach

Acta Pharm. 2020 Dec 1;70(4):465-482. doi: 10.2478/acph-2020-0036.

Abstract

Offering a systematic and multivariate analysis of the analytical procedure, development and validation of HPLC methods using Quality by Design approach are in the limelight of current research trends. A new, experimental design-aided HPLC method for fampridine was developed and preliminarily validated according to current in-force international guidelines for linearity, accuracy, robustness and precision. The method offers a high throughput sample analysis, with an elution time of 2.9 minutes, and signal detection without excipient interference performed at 262 nm. The method proved to be linear between 1-15 µg mL-1 (R2= 0.9996). The mean recovery was found to be 98.7 ± 1.9 % in the tested range of 2.5-7.5 µg mL-1. Low RSD values (< 1 %) were obtained for both model, intra- and inter-day precision. The limit of detection and limit of quantification were 0.24 and 0.78 µg mL-1, resp. The method proved to be applicable for active substance assay in a pharmaceutical dosage form.

Keywords: Analytical Quality by Design; HPLC; fampridine.

MeSH terms

  • 4-Aminopyridine / analysis*
  • Chromatography, High Pressure Liquid / methods*
  • Delayed-Action Preparations / analysis
  • Dosage Forms
  • Drug Design*
  • Excipients
  • Indicators and Reagents
  • Limit of Detection
  • Potassium Channel Blockers / analysis*
  • Quality Control*
  • Reproducibility of Results
  • Signal Processing, Computer-Assisted
  • Tablets

Substances

  • Delayed-Action Preparations
  • Dosage Forms
  • Excipients
  • Indicators and Reagents
  • Potassium Channel Blockers
  • Tablets
  • 4-Aminopyridine